Patient's Psychological Attitude and Glycemic control Effectiveness by GLP-1 (PAGE-1)
- Conditions
- type 2 diabetes
- Registration Number
- JPRN-UMIN000007159
- Lead Sponsor
- Japan society for Patient Reported Outcome
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 300
Not provided
1) Patients not prescribed liraglutide in accordance with the recommendations by the "Committee on the proper use of incretins (GLP-1 receptor agonists and DPP-4 inhibitors)" 2) Patients with previous or current treatment with insulin formulations 3) Patients receiving previous treatment with GLP-1 receptor agonists 4) Patients with hypersensitivity to this drug or excipient 5) Female patients being pregnant/breast-feeding or desiring to become pregnant within the next 12 months 6) Patients with malignancies 7) Patients meeting the contraindications for GLP-1 receptor agonist (18 mg Victoza; subcutaneous injection) (liraglutide) 8) Patients with severe complications resulting from diabetes or other causes 9) Other patients determined ineligible by an investigator
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method